Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for American Well Corporation (AMWL : NYSE)

• Company Description    American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. Number of Employees: 877

• Price / Volume Information    Yesterday's Closing Price: $4.21 Daily Weekly Monthly 20 Day Moving Average: 104,781 shares Shares Outstanding: 16.15 (millions) Market Capitalization: $68.00 (millions) Beta: 1.24 52 Week High: $12.95 52 Week Low: $4.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.66% -29.56% 12 Week -41.12% -43.56% Year To Date -41.93% -49.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 75 STATE STREET 26TH FLOOR - Boston,MA 02109 USA ph: 617-204-3500 fax: - investors@amwell.com http://www.americanwell.com

• General Corporate Information    Officers Ido Schoenberg - Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Paul McNeice - Chief Accounting Officer Roy Schoenberg - Director Rivka Goldwasser - Director Peer Information American Well Corporation (HLIS) American Well Corporation (AZTA) American Well Corporation (APYI) American Well Corporation (RNVA) American Well Corporation (HMSY) American Well Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 03044L204 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/11/26 Share - Related Items Shares Outstanding: 16.15 Most Recent Split Date: 7.00 (0.05:1) Beta: 1.24 Market Capitalization: $68.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.80 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-6.59 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.25 Price/Cash Flow: - Price / Sales: 0.26 EPS Growth vs. Year Ago Period: 39.37% vs. Previous Quarter: -40.32% Sales Growth vs. Year Ago Period: -7.80% vs. Previous Quarter: -20.61% ROE 09/30/25 - -39.80 06/30/25 - -41.99 03/31/25 - -48.36 ROA 09/30/25 - -29.38 06/30/25 - -30.80 03/31/25 - -35.36 Current Ratio 09/30/25 - 3.14 06/30/25 - 3.29 03/31/25 - 2.92 Quick Ratio 09/30/25 - 3.11 06/30/25 - 3.27 03/31/25 - 2.89 Operating Margin 09/30/25 - -44.45 06/30/25 - -49.29 03/31/25 - -62.37 Net Margin 09/30/25 - -42.80 06/30/25 - -46.15 03/31/25 - -59.13 Pre-Tax Margin 09/30/25 - -41.34 06/30/25 - -45.36 03/31/25 - -58.29 Book Value 09/30/25 - 16.55 06/30/25 - 18.24 03/31/25 - 19.59 Inventory Turnover 09/30/25 - 53.69 06/30/25 - 44.65 03/31/25 - 37.10 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©